Nilotinib versus imatinib: Molecular mechanism(s) of its better efficacy

Cancer

Volumn 118, Issue 20, 2012, Pages 5180-5181

  Bakalova, Rumiana ^a,b   Zhelev, Zhivko ^a   Spasov, Lubomir ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB; NILOTINIB; TELOMERASE;

CHROMOSOME SIZE; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENOMIC INSTABILITY; HUMAN; LETTER; MITOSIS INHIBITION; PRIORITY JOURNAL; TELOMERE HOMEOSTASIS;

ANTINEOPLASTIC AGENTS; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PIPERAZINES; PYRIMIDINES;

EID: 84867335606     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27479     Document Type: Letter

References (6)

1. Nicolini FE, Turkina A, Shen ZX, et al. Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase. Cancer. 2012; 118: 118-126.
2. Radich JP,. Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia. Cancer. 2012; 118: 300-311.
3. Engelhardt M, Mackenzie K, Drullinsky P, et al. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Cancer Res. 2000; 60: 610-617.
4. Bakalova R, Ohba H, Zhelev Z, et al. Antisense inhibition of bcr-abl/c-abl synthesis promotes telomerase activity and up-regulates tankyrase in human leukaemia cells. FEBS Lett. 2004; 564: 73-84.
5. Breccia M, Alimena G,. The current role of high-dose imatinib in chronic myeloid leukemia patients, newly diagnosed or resistant to standard dose. Expert Opin Pharmacother. 2011; 12: 2075-2087.
6. Shapira S, Granot G, Mor-Tzuntz R, et al. The effect of nilotinib and dasatinib on telomerase activity and regulation in K562 cells. Haematologica. 2010; 95 (suppl. 2): 34. Abstract 0086.